SCHEMBL7527995

SCHEMBL7527995

COC(=O)CCc1cc(-n2nc3ccccc3n2)c(O)c(C(C)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
POLB P06746 2/20 0.41
MAOB P27338 3/20 0.39
MAOA P21397 2/20 0.39
GAA P10253 3/20 0.37
ACHE P22303 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALOX5 P09917 2/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
AGTR1 P30556 1/20 0.36
HTT P42858 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7521604 0.92 KDM4E (0.42) KDM4EPOLBMAOBMAOAGAA
SCHEMBL7523053 0.91 KDM4E (0.35) KDM4EPOLBMAOBMAOAGAA
SCHEMBL7692453 0.89 NPC1 (0.38) POLBMAOBMAOAGAAACHE
SCHEMBL31360 0.89 GAA (0.47) KDM4EPOLBMAOBMAOAGAA
SCHEMBL7068865 0.89 GAA (0.47) KDM4EPOLBMAOBMAOAGAA
SCHEMBL29350844 0.89 GAA (0.47) KDM4EPOLBMAOBMAOAGAA
SCHEMBL7522007 0.89 ALOX5 (0.41) KDM4EPOLBMAOBMAOAGAA
SCHEMBL7593809 0.88 MAOB (0.45) KDM4EPOLBMAOBMAOAGAA
SCHEMBL6864209 0.84 KDM4E (0.39) KDM4EPOLBMAOBMAOAGAA
SCHEMBL5835062 0.84 KDM4E (0.42) KDM4EPOLBMAOBMAOAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489383-B1 SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES CIBA SPECIALTY CHEMICALS CORPORATION 2002-12-03 US disclosed
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith WOOD MERVIN G (US) 2002-11-14 US disclosed
US-6392056-B1 FOR THERMOPLASTIC RESINS CIBA SPECIALTY CHEMICAL CORPORATION 2002-05-21 US disclosed
WO-2002012204-A1 2H-BENZOTRIAZOLE UV ABSORBERS SUBSTITUTED WITH 1,1-DIPHENYLALKYL GROUPS AND COMPOSITIONS STABILIZED THEREWITH CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith SUV39H1, SUV39H2, PAH KDM4E 175/4885POLB 1272/4885MAOB 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.